Wilson Sonsini Goodrich & Rosati advised Adanate on the deal. Adanate, a biotech company focusing on therapies in oncology and immunology, recently raised $30 million in...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here